Owens & Minor Q2 EPS Forecast Decreased by Leerink Partnrs

Owens & Minor, Inc. (NYSE:OMI) – Investment analysts at Leerink Partnrs lowered their Q2 2025 earnings per share (EPS) estimates for shares of Owens & Minor in a research report issued to clients and investors on Thursday, February 20th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $0.01 for the quarter, down from their previous estimate of $0.39. The consensus estimate for Owens & Minor’s current full-year earnings is $1.51 per share. Leerink Partnrs also issued estimates for Owens & Minor’s FY2025 earnings at $1.20 EPS.

Other research analysts also recently issued reports about the stock. Barclays decreased their target price on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 5th. Citigroup decreased their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. UBS Group lowered their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Finally, Robert W. Baird dropped their target price on Owens & Minor from $15.00 to $14.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 4th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $16.79.

Owens & Minor Stock Down 2.7 %

NYSE OMI opened at $6.23 on Monday. The stock has a market cap of $480.01 million, a PE ratio of -9.58, a P/E/G ratio of 0.20 and a beta of 0.48. The business has a 50 day moving average price of $12.06 and a two-hundred day moving average price of $13.51. Owens & Minor has a fifty-two week low of $6.07 and a fifty-two week high of $28.35. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11.

Hedge Funds Weigh In On Owens & Minor

A number of hedge funds have recently modified their holdings of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Owens & Minor by 29.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 219,761 shares of the company’s stock worth $2,872,000 after acquiring an additional 50,184 shares during the period. Voloridge Investment Management LLC lifted its stake in shares of Owens & Minor by 24.2% in the fourth quarter. Voloridge Investment Management LLC now owns 243,525 shares of the company’s stock worth $3,183,000 after buying an additional 47,459 shares during the last quarter. Squarepoint Ops LLC bought a new stake in Owens & Minor during the fourth quarter valued at about $381,000. State of Wyoming boosted its stake in Owens & Minor by 35.3% during the 4th quarter. State of Wyoming now owns 23,198 shares of the company’s stock valued at $303,000 after purchasing an additional 6,050 shares during the period. Finally, ProShare Advisors LLC grew its stake in shares of Owens & Minor by 44.5% in the fourth quarter. ProShare Advisors LLC now owns 22,702 shares of the company’s stock worth $297,000 after acquiring an additional 6,996 shares during the last quarter. 98.04% of the stock is currently owned by institutional investors and hedge funds.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.